187 related articles for article (PubMed ID: 24367007)
1. Role of ATP-sensitive K+ channels in cardiac arrhythmias.
Nakaya H
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):237-43. PubMed ID: 24367007
[TBL] [Abstract][Full Text] [Related]
2. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
Billman GE
Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091
[TBL] [Abstract][Full Text] [Related]
3. ATP-sensitive potassium currents from channels formed by Kir6 and a modified cardiac mitochondrial SUR2 variant.
Aggarwal NT; Shi NQ; Makielski JC
Channels (Austin); 2013; 7(6):493-502. PubMed ID: 24037327
[TBL] [Abstract][Full Text] [Related]
4. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
Yamada S; Kane GC; Behfar A; Liu XK; Dyer RB; Faustino RS; Miki T; Seino S; Terzic A
J Physiol; 2006 Dec; 577(Pt 3):1053-65. PubMed ID: 17038430
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone inhibits sarcolemmal but not mitochondrial KATP channels in Guinea pig ventricular cells.
Sato T; Takizawa T; Saito T; Kobayashi S; Hara Y; Nakaya H
J Pharmacol Exp Ther; 2003 Dec; 307(3):955-60. PubMed ID: 14534361
[TBL] [Abstract][Full Text] [Related]
6. Identification and pharmacological characterization of sarcolemmal ATP-sensitive potassium channels in the murine atrial HL-1 cell line.
Fox JE; Jones L; Light PE
J Cardiovasc Pharmacol; 2005 Jan; 45(1):30-5. PubMed ID: 15613976
[TBL] [Abstract][Full Text] [Related]
7. [Molecular and functional diversity of ATP-sensitive K+ channels: the pathophysiological roles and potential drug targets].
Nakaya H; Miki T; Seino S; Yamada K; Inagaki N; Suzuki M; Sato T; Yamada M; Matsushita K; Kurachi Y; Arita M
Nihon Yakurigaku Zasshi; 2003 Sep; 122(3):243-50. PubMed ID: 12939542
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels.
Hu H; Sato T; Seharaseyon J; Liu Y; Johns DC; O'Rourke B; Marbán E
Mol Pharmacol; 1999 Jun; 55(6):1000-5. PubMed ID: 10347240
[TBL] [Abstract][Full Text] [Related]
9. Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery.
Light PE; Kanji HD; Fox JE; French RJ
FASEB J; 2001 Dec; 15(14):2586-94. PubMed ID: 11726534
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone decanoate negatively reverses the beneficial effects of exercise on cardiac muscle via sarcolemmal, but not mitochondrial K(ATP) channel.
Bayat G; Javan M; Safari F; Khalili A; Shokri S; Goudarzvand M; Salimi M; Hajizadeh S
Can J Physiol Pharmacol; 2016 Mar; 94(3):324-31. PubMed ID: 26909616
[TBL] [Abstract][Full Text] [Related]
11. Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.
Zhang DM; Chai Y; Erickson JR; Brown JH; Bers DM; Lin YF
J Physiol; 2014 Mar; 592(5):971-90. PubMed ID: 24277866
[TBL] [Abstract][Full Text] [Related]
12. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning.
Maack C; Dabew ER; Hohl M; Schäfers HJ; Böhm M
Circ Res; 2009 Oct; 105(8):811-7. PubMed ID: 19729596
[TBL] [Abstract][Full Text] [Related]
13. Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A.
Lorenz E; Terzic A
J Mol Cell Cardiol; 1999 Feb; 31(2):425-34. PubMed ID: 10093054
[TBL] [Abstract][Full Text] [Related]
14. Sarcolemmal ATP-sensitive potassium channel protects cardiac myocytes against lipopolysaccharide-induced apoptosis.
Zhang X; Zhang X; Xiong Y; Xu C; Liu X; Lin J; Mu G; Xu S; Liu W
Int J Mol Med; 2016 Sep; 38(3):758-66. PubMed ID: 27430376
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.
Medeiros-Domingo A; Tan BH; Crotti L; Tester DJ; Eckhardt L; Cuoretti A; Kroboth SL; Song C; Zhou Q; Kopp D; Schwartz PJ; Makielski JC; Ackerman MJ
Heart Rhythm; 2010 Oct; 7(10):1466-71. PubMed ID: 20558321
[TBL] [Abstract][Full Text] [Related]
17. Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
Sato T; Costa AD; Saito T; Ogura T; Ishida H; Garlid KD; Nakaya H
J Pharmacol Exp Ther; 2006 Jan; 316(1):182-8. PubMed ID: 16174795
[TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels.
Lawrence CL; Rainbow RD; Davies NW; Standen NB
Br J Pharmacol; 2002 Jul; 136(5):746-52. PubMed ID: 12086984
[TBL] [Abstract][Full Text] [Related]
19. Sarcolemmal KATP channel modulators and cardiac arrhythmias.
Baczkó I; Husti Z; Lang V; Leprán I; Light PE
Curr Med Chem; 2011; 18(24):3640-61. PubMed ID: 21774762
[TBL] [Abstract][Full Text] [Related]
20. Kir6.2 limits Ca(2+) overload and mitochondrial oscillations of ventricular myocytes in response to metabolic stress.
Storey NM; Stratton RC; Rainbow RD; Standen NB; Lodwick D
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1508-18. PubMed ID: 24014680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
